2025년 10월 27일

Where Vision Meets Validation: The Next Chapter for XRP Healthcare

For XRP Healthcare, the path from concept to public markets represents not just financial growth, but a powerful commitment to revolutionizing healthcare across emerging regions through innovation, precision, and

이 문서는 현재 영어로 제공됩니다.

Where Vision Meets Validation: The Next Chapter for XRP Healthcare

For XRP Healthcare, the path from concept to public markets represents not just financial growth, but a powerful commitment to revolutionizing healthcare across emerging regions through innovation, precision, and tangible execution.

A Mission with Measurable Impact

What began as a pioneering idea on the XRP Ledger has evolved into a comprehensive healthcare ecosystem that bridges technology, real-world assets, and global partnerships to create measurable, lasting change. As XRP Healthcare advances toward a proposed public listing, its mission remains anchored in three principles: transparency, credibility, and value creation—for both patients and shareholders alike. The company’s strategy rests on two powerful pillars: Mergers & Acquisitions (M&A) and Artificial Intelligence (AI). Together, these form the framework for a scalable, technology-driven healthcare system that empowers communities locally and globally.

Building Infrastructure Through M&A

Through its M&A division, XRP Healthcare has already established a strong regional presence in East Africa with the acquisition of PharmaVille, a Ugandan pharmacy chain spanning wholesale and retail operations. This move marks the beginning of a wider consolidation strategy aimed at modernizing private healthcare networks and improving accessibility across the continent. Each acquisition is more than a business transaction—it’s a building block toward a connected, efficient, and patient-centered healthcare ecosystem.

XRPH AI – Smarter, Safer, and More Inclusive Care

While M&A expands physical access, XRPH AI is transforming digital engagement. This intelligent platform empowers users with region-specific medical insights, holistic health assessments, doctor-connect functionality, multilingual support, and even a U.S. prescription savings card usable across 68,000+ pharmacies.

In addition, XRPH AI combats counterfeit medicines through its prescription verification system, allowing users to validate drug authenticity within seconds—protecting lives and strengthening trust. By merging human expertise with technological intelligence, XRPH AI is becoming a global digital companion that bridges healthcare gaps through innovation, accessibility, and integrity.

The Road to Public Markets

The proposed listing of XRP Healthcare M&A Holding Inc. on the TSX Venture Exchange (TSXV) marks a defining milestone—validation at scale. This step underscores the company’s dedication to governance, transparency, and sustainable growth, while paving the way for broader institutional participation and international expansion.

For investors, it’s an opportunity to engage with one of the most credible healthcare innovation stories emerging from frontier markets. For patients and partners, it ensures long-term continuity, accountability, and trust.

Scaling Purpose with Performance

The upcoming listing is expected to accelerate both strategic fronts—expanding M&A operations across Africa and propelling XRPH AI’s global rollout. Together, these initiatives form a unified model: acquisitions enhance healthcare infrastructure, while AI amplifies accessibility, efficiency, and patient empowerment.

Purpose. Proof. Progress.

XRP Healthcare’s mission extends beyond growth—it’s about growth with purpose, grounded in discipline, compliance, and innovation that serves humanity before markets. As the company enters its next chapter, it embodies a balance of vision and execution—a journey toward accessible, technology-driven healthcare for millions worldwide.

Because real validation doesn’t stem from ambition alone—it’s earned through results. And those results are now unfolding.   Forward-Looking Statements   This document contains “forward-looking statements” under applicable securities laws, including statements about the proposed listing of XRP Healthcare M&A Holding Inc. on the TSX Venture Exchange (TSXV), anticipated timelines, future growth, business objectives, and strategic plans.

Forward-looking statements are based on current assumptions and may involve known and unknown risks that could cause actual outcomes to differ materially. There is no assurance that the listing or any related transaction will occur as proposed or at all. XRP Healthcare M&A Holding Inc. assumes no obligation to update or revise these statements except as required by law.

Public-Market Readiness & Institutional Narrative


소매 네트워크 접근

소매 네트워크 접근은 United Networks of America(UNA)와의 계약을 통해 제공됩니다. 약국 브랜드 표시가 XRP Healthcare M&A Holding Inc.의 소유, 보증 또는 직접적인 파트너십을 의미하지는 않습니다.

전략적 헬스 테크 파트너십

기술 파트너십은 협업 또는 프로젝트 기반 협력을 의미합니다. 명시적으로 공개되지 않는 한 지분 소유나 보증을 의미하지 않습니다.

제약 및 공급 파트너십

제약 및 공급 관계는 인수된 운영 법인 내 기존 상업적 계약을 반영합니다. 표준 상업 공급 계약을 넘어 독점성이나 보증을 의미하지 않습니다.

고문

고문은 XRP Healthcare M&A Holding Inc.에 전문 서비스를 제공합니다. 공개적으로 공시되지 않는 한 파트너십이나 소유 지분을 의미하지 않습니다.

모든 제3자 상표는 각 소유자의 재산입니다. 명시적으로 언급되지 않는 한 표시가 보증, 소유권 또는 파트너십을 의미하지 않습니다.

Where Vision Meets Validation: The Next Chapter for XRP Healthcare